跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 64,368 条关于
“Prescription Drug User Fee Act”
全部
64,368
临床试验
37,266
药物
1,637
机构
427
资讯
25,038
去年
FDA Initiates PDUFA VIII Reauthorization Process with Public Meeting and Assessment Report
去年
FDA Accepts Donidalorsen NDA for Hereditary Angioedema Prophylaxis
去年
FDA's December Calendar Features Nine PDUFA Dates
去年
FDA Sets PDUFA Date for Neffy Nasal Spray and Approves Crinecerfont for CAH Treatment
去年
FDA Sets PDUFA Date for Gene Therapy Targeting AADC Deficiency
8个月前
Unicycive Therapeutics Resubmits NDA for Novel Phosphate Binder Targeting Hyperphosphatemia in Dialysis Patients
去年
FDA Issues Complete Response Letter for Astellas' IZERVAY and Accepts Aldeyra's NDA for Reproxalap
去年
FDA Advisory Committee Rejects Zynquista for Type 1 Diabetes and Chronic Kidney Disease
去年
FDA Deputy Commissioner Signals Potential Reforms to PDUFA Program
去年
FDA Accepts Unicycive's NDA for Oxylanthanum Carbonate in CKD Patients on Dialysis
第 1 页，共 2504 页
上一页
下一页
